胃泌素抑制肽(GIP)重组蛋白

Recombinant Gastric Inhibitory Polypeptide (GIP)

Incretin hormone; Glucose Dependent Insulinotropic Peptide

  • 胃泌素抑制肽(GIP)重组蛋白 产品包装(模拟)
  • 胃泌素抑制肽(GIP)重组蛋白 产品包装(模拟)
  • 胃泌素抑制肽(GIP)重组蛋白 Figure. Gene Sequencing (Extract)
  • RPA882Hu01.jpg SDS-PAGE图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPA882Hu01 胃泌素抑制肽(GIP)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
CPA882Hu11 胃泌素抑制肽(GIP)牛血清白蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPA882Hu21 胃泌素抑制肽(GIP)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
PAA882Hu08 胃泌素抑制肽(GIP)多克隆抗体 WB; IHC; ICC; IP.
PAA882Hu01 胃泌素抑制肽(GIP)多克隆抗体 WB; IHC; ICC; IP.
MAA882Hu21 胃泌素抑制肽(GIP)单克隆抗体 WB,IHC
MAA882Hu22 胃泌素抑制肽(GIP)单克隆抗体 WB; IHC; ICC; IP.
CEA882Hu 胃泌素抑制肽(GIP)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA882Hu 胃泌素抑制肽(GIP)等多因子检测试剂盒(流式荧光发光法) FLIA Assay for Antigen Detection.
KSA882Hu11 胃泌素抑制肽(GIP)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Scientific Reports The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlyingsignaling mechanisms in a rat model of diabetes mellitus. [pubmed:27721485]
Obesity surgery The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. [pubmed:28840471]
Obesity Surgery  Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague … [Pubmed:29098544]
BioMed Research International Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity []
Diabetes Research and Clinical Practice Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients [Pubmed: 31734225]
OBESITY SURGERY The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats [Pubmed: 31701411]
FUTURE SCIENCE Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes [Pubmed:35251693]
留言咨询